Potential of Heparin in the Treatment of COVID-19-Associated Myocarditis. | Pediatr Emerg Care;38(2): e504, 2022 02 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Potential of Heparin in the Treatment of COVID-19-Associated Myocarditis.

Yu, Xianqiang.

Yu X; Southeast University Medical School, Nanjing, China yuxianqiang302@126.com.

Pediatr Emerg Care ; 38(2): e504, 2022 02 01.

Article in English | MEDLINE | ID: covidwho-1662154

Subject(s)

COVID-19; Myocarditis; Heparin/adverse effects; Humans; Myocarditis/chemically induced; Myocarditis/drug therapy; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Limits: Humans Language: English Journal: Pediatr Emerg Care Journal subject: Emergency Medicine / Pediatrics Year: 2022 Document Type: Article Affiliation country: Pec.0000000000002645

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Limits: Humans Language: English Journal: Pediatr Emerg Care Journal subject: Emergency Medicine / Pediatrics Year: 2022 Document Type: Article Affiliation country: Pec.0000000000002645